.png)
Summary
Data Protection: Addressing Noise, Speech, and Voice Concerns
Here's our newest conversation with Brij Mohan Lal Srivastava, CEO and Co-founder of Nijta, a company at the forefront of AI in speech anonymization. The realm of voice is an emerging and fascinating area within the life sciences, and with every new domain, issues of privacy come to the forefront.
In this discussion, we converse with Brij Mohan Lal Srivastava, who is the co-founder and CEO of Nijta, a company that focuses on developing AI-powered solutions for data anonymization and pseudonymization. These solutions are becoming increasingly important in clinical research, particularly with the emergence of voice as an important biomarker for identifying diseases such as depression. We delve into the fundamentals of noise, speech, and voice, and also explore how Nijta's technologies can be applied in the life sciences sector.
FAQs
Our frequently questions
Find out how iliomad can help your company.
Only visible in production
EU Digital Omnibus Simplifies AI Act Obligations; Rhode Island Enacts AI Healthcare Laws
Regulation (EU) 2026/1744 streamlines EU AI Act compliance, while Rhode Island enacts three AI healthcare laws. Key updates for biotech and healthtech teams.
EDPB Anonymisation Guidelines 2026 and Clinical Trial Data: What Life Sciences Organisations Must Know
EDPB Guidelines 02/2026 on anonymisation set new standards for clinical trial data. Learn the three-criteria test, enforcement lessons and compliance steps. iliomad.
AI Triage, Biopharma Workbenches and Crumbling Data Bridges: iliomad Weekly Digest
NHS AI triage, Anthropic Claude Science, medical AI privacy risks, MHRA GxP guidance, EDPS ADM checklist and the EU-US data transfer threat explained.
